Xenleta
Product Images NDC 72000-120

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Xenleta (NDC 72000-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nabriva Therapeutics Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Xenleta 01)

Chemical structure diagram showing the molecular structure of the active ingredient in Xenleta, including rings, functional groups, and stereochemistry.*

FDA Label Image

Injection Vial Label (Xenleta 02)

Xenleta (lefamulin) injection 150 mg/15 mL single-dose vial label by Nabriva Therapeutics US, Inc. The label includes dosage concentration, dilution warning for intravenous infusion only, storage instructions to refrigerate at 2°C to 8°C, and directions to protect from freezing. It also displays the NDC number, lot number, expiration date placeholder, and manufacturer information.*

FDA Label Image

Injection Carton Label (Xenleta 03)

Carton label for Xenleta (lefamulin) injection 150 mg/15 mL, a sterile, non-pyrogenic injection supplied in 6 single-dose vials. Each vial contains 168 mg lefamulin acetate equivalent to 150 mg lefamulin. The label includes warnings for dilution before use and storage instructions, manufactured for Nabriva Therapeutics US, Inc.*

FDA Label Image

Diluent Bag Label (Xenleta 04)

Diluent for Xenleta (lefamulin) injection, 250 mL vial label. Contains citrate buffered 10 mM and 0.9% sodium chloride injection. Manufactured for Nabriva Therapeutics US, Inc, King of Prussia, PA. Label includes storage and usage instructions, with barcode and lot/expiration date fields.*

FDA Label Image

Diluent Carton Label (Xenleta 05)

Packaging label for Xenleta diluent by Nabriva Therapeutics US, Inc. The diluent is 10 mM Citrate Buffered 0.9% Sodium Chloride Injection, sterile and non-pyrogenic, intended for intravenous infusion only. The label specifies 6 single-dose IV bags, each 250 mL, with warnings for proper dilution and infusion time over 60 minutes.*

FDA Label Image

Tablet 30-count Bottle Label (Xenleta 06)

Label for Xenleta (lefamulin) tablets 600 mg manufactured for Nabriva Therapeutics US, Inc. The label indicates 30 tablets per container, with storage instructions between 20°C to 25°C. It includes dosage administration notes, lot number, expiration date, and unique barcodes for identification.*

FDA Label Image

Xenleta 07

Xenleta (lefamulin) tablets 600 mg packaging label for a 10-count oral pack by Nabriva Therapeutics US, Inc. The label includes a color-coded blister card showing dosing for Day 1 to Day 5 with doses 1 and 2 each day. Instructions for tablet dispensing and important administration instructions are also present on the packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.